Tolerance to δ-but not μ-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by β-endorphin administered intracerebroventricularly in mice

[1]  H. H. Suh,et al.  Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by β-endorphin and morphine, administered intracerebroventricularly , 1990, Neuropharmacology.

[2]  H. H. Suh,et al.  Intrathecal [Met5]enkephalin antibody blocks analgesia induced by intracerebroventricular beta-endorphin but not morphine in mice. , 1989, European journal of pharmacology.

[3]  J. Fujimoto,et al.  Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice. , 1989, European journal of pharmacology.

[4]  L. Tseng,et al.  Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice. , 1988, The Journal of pharmacology and experimental therapeutics.

[5]  G. Gebhart,et al.  Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure. , 1988, The Journal of pharmacology and experimental therapeutics.

[6]  C. Advokat,et al.  Investigation of tolerance to chronic intrathecal morphine infusion in the rat , 1987, Physiology & Behavior.

[7]  H. Mosberg,et al.  Opioid δ-receptor involvement in supraspinal and spinal antinociception in mice , 1987, Brain Research.

[8]  G. Wilcox,et al.  Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. , 1987, The Journal of pharmacology and experimental therapeutics.

[9]  B. Milne,et al.  Monoamine and opioid interactions in spinal analgesia and tolerance , 1987, Pharmacology Biochemistry and Behavior.

[10]  B. Milne,et al.  Determination of cross tolerance in rat spinal cord using intrathecal infusion via sequential mini-osmotic pumps , 1987, Pharmacology Biochemistry and Behavior.

[11]  J. Fujimoto,et al.  Release of immunoreactive met-enkephalin by intraventricular beta-endorphin in anesthetized rats , 1986, Regulatory Peptides.

[12]  J. Fujimoto,et al.  Spinal release of immunoreactive Met-enkephalin by intraventricular beta-endorphin and its analogs in anesthetized rats. , 1986, The Journal of pharmacology and experimental therapeutics.

[13]  T. Jensen,et al.  II. Examination of spinal monoamine receptors through which brainstem opiate-sensitive systems act in the rat , 1986, Brain Research.

[14]  J. Fujimoto,et al.  Release of immunoreactive met-enkephalin from the spinal cord by intraventricular β-endorphin but not morphine in anesthetized rats , 1985, Brain Research.

[15]  B. Milne,et al.  Analgesia and tolerance to intrathecal morphine and norepinephrine infusion via implanted mini-osmotic pumps in the rat , 1985, Pain.

[16]  J. Fujimoto,et al.  Evidence that spinal endorphin mediates intraventricular β-endorphin-induced tail flick inhibition and catalepsy , 1984, Brain Research.

[17]  H. Takagi,et al.  Separate involvement of the spinal noradrenergic and serotonergic systems in morphine analgesia: the differences in mechanical and thermal algesic tests , 1983, Brain Research.

[18]  L. Tseng.  Partial cross tolerance to D-Ala2-D-Leu5-enkephalin after chronic spinal morphine infusion. , 1983, Life sciences.

[19]  A. Takemori,et al.  Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. , 1983, The Journal of pharmacology and experimental therapeutics.

[20]  T. Yaksh,et al.  In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord , 1982, Brain Research.

[21]  L. Tseng.  Tolerance and cross tolerance to morphine after chronic spinal D-Ala2-D-Leu5-enkephalin infusion. , 1982, Life sciences.

[22]  P. Portoghese,et al.  Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine. , 1982, The Journal of pharmacology and experimental therapeutics.

[23]  G. Wilcox,et al.  Intrathecal morphine in mice: a new technique. , 1980, European journal of pharmacology.

[24]  H. Takagi,et al.  Noradrenaline regulation of pain-transmission in the spinal cord mediated by α-adrenoceptors , 1979, Brain Research.

[25]  T. Yaksh.  Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray , 1979, Brain Research.

[26]  T. Yaksh,et al.  Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. , 1977, European journal of pharmacology.

[27]  T. Haley,et al.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. , 1957, British journal of pharmacology and chemotherapy.

[28]  N. B. Eddy,et al.  Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. , 1953, The Journal of pharmacology and experimental therapeutics.

[29]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.

[30]  Fred E. D'Amour,et al.  A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .

[31]  W. Watkins,et al.  Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors. , 1987, The Journal of pharmacology and experimental therapeutics.

[32]  J. Fujimoto,et al.  Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats. , 1985, The Journal of pharmacology and experimental therapeutics.

[33]  Kuraishi Yasushi,et al.  Microinjection of opioids into the nucleus reticularis gigantocellularis of the rat: Analgesia and increase in the normetanephrine level in the spinal cord , 1978 .